This article was published in Law360 on October 31, 2017. © Copyright 2017, Portfolio Media, Inc., publisher of Law360. It is republished here with permission.
The 46 attorneys general accusing six drug companies of conspiring to fix the price of two generic drugs said Tuesday they’re asking a Pennsylvania federal court for permission to massively expand their suit by targeting 12 more drug companies, 13 more drugs, and Mylan and Emcure executives.
Jan P. Levine acted as liaison counsel for the drug companies.